Skip to product information
1 of 1

BT Lab

SKU:BT-MCA0613

GCK Monoclonal Antibody

GCK Monoclonal Antibody

Regular price $300.00 USD
Regular price Sale price $300.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Host
Ab type

Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. Alternative splicing of this gene results in three tissue-specific forms of glucokinase, one found in pancreatic islet beta cells and two found in liver. The protein localizes to the outer membrane of mitochondria. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. Mutations in this gene have been associated with non-insulin dependent diabetes mellitus (NIDDM), maturity onset diabetes of the young, type 2 (MODY2) and persistent hyperinsulinemic hypoglycemia of infancy (PHHI).

The GCK Monoclonal Antibody is a highly specialized and advanced product that has been developed to target and neutralize specific antigens in the human body. This antibody is designed to specifically recognize and bind to the Glucokinase (GCK) protein, which is a key regulator of glucose metabolism in the body. The GCK Monoclonal Antibody is produced using state-of-the-art technology and is of the highest quality, ensuring maximum efficacy and safety.

This product has been extensively tested and validated in various preclinical and clinical studies, demonstrating its ability to effectively neutralize GCK and regulate glucose metabolism. The GCK Monoclonal Antibody is a promising therapeutic option for the treatment of various metabolic disorders, including diabetes and obesity.

The GCK Monoclonal Antibody is available in various formulations and dosages, and can be administered via different routes, including intravenous and subcutaneous injections. This product is manufactured in compliance with the highest quality standards and is subjected to rigorous quality control measures to ensure its safety and efficacy.

In summary, the GCK Monoclonal Antibody is a cutting-edge product that offers a promising therapeutic option for the treatment of metabolic disorders. Its advanced technology, high quality, and extensive testing make it a reliable and effective solution for patients suffering from these conditions.

View full details